Skip to main content

Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion

Press releases | May 16, 2023

Fried Frank acted as counsel to BofA Securities as financial advisor to Syneos Health, Inc. (Nasdaq: SYNH) in its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital in a transaction valued at approximately $7.1 billion, including outstanding debt. Syneos Health is a leading, fully integrated biopharmaceutical solutions organization with a team of professionals who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. The transaction is expected to close in the second half of 2023. 

The Fried Frank team was led by partner Roy Tannenbaum.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.